| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |